<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04085614</url>
  </required_header>
  <id_info>
    <org_study_id>XCY612-130576</org_study_id>
    <nct_id>NCT04085614</nct_id>
  </id_info>
  <brief_title>Dynamic Coronary Roadmap for Contrast Reduction</brief_title>
  <acronym>DCR4Contrast</acronym>
  <official_title>Dynamic Coronary Roadmap for Contrast Reduction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Dynamic Coronary Roadmap is a commercially available product developed by Philips Medical
      Systems, a Philips Healthcare company. Dynamic Coronary Roadmap is a software medical device
      intended to provide a real-time and dynamic angiographic roadmap of coronary arteries. The
      angiographic roadmap is automatically generated from previously acquired coronary angiograms
      during the same procedure. Dynamic Coronary Roadmap overlays the angiographic roadmap on live
      2D fluoroscopic images, thereby assisting the physician in navigating devices, e.g. (guide)
      wires, catheters, through the coronary arteries.

      This is a multi-center, prospective, unblinded, stratified 1:1 randomized controlled trial to
      assess whether using Dynamic Coronary Roadmap reduces the total iodinated contrast volume
      related to PCI compared to the control group without Dynamic Coronary Roadmap.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective:

      • To assess whether using Dynamic Coronary Roadmap reduces the total iodinated contrast
      volume related to PCI compared to the control group without Dynamic Coronary Roadmap.

      Secondary objective:

      • To assess the total number of contrast enhanced cine angiographic X-ray runs (angiograms)
      related to PCI in the Dynamic Coronary Roadmap and control group
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total PCI iodinated contrast volume</measure>
    <time_frame>During PCI procedure</time_frame>
    <description>Average total undiluted iodinated contrast volume (in ml) used per PCI (from first positioning the interventional guiding catheter in stable coronary position till end of PCI procedure) measured by an automatic contrast injector.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of angiograms</measure>
    <time_frame>During PCI procedure</time_frame>
    <description>Average total number of contrast enhanced cine angiographic X-ray runs (angiograms) per PCI (from first positioning the interventional guiding catheter in stable coronary position till end of PCI procedure) determined via visual assessment (e.g., on the Philips X-ray system)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">394</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Dynamic Coronary Roadmap group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be treated via standard of care for PCI with navigation support of Dynamic Coronary Roadmap.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be treated via standard of care for PCI without navigation support of Dynamic Coronary Roadmap.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PCI with Dynamic Coronary Roadmap</intervention_name>
    <description>Standard of care PCI with Dynamic Coronary Roadmap</description>
    <arm_group_label>Dynamic Coronary Roadmap group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PCI without Dynamic Coronary Roadmap</intervention_name>
    <description>Standard of care PCI without Dynamic Coronary Roadmap</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is undergoing Percutaneous Coronary Intervention (PCI) with a degree of
             complexity that anticipates the need for more than 25ml of iodinated contrast volume

          -  Subject has signed informed consent

          -  Subject is 18 years of age or older, or of legal age to give informed consent per
             state or national law

        Exclusion Criteria:

          -  Subject undergoing emergency PCI

          -  Subject with ST-segment Elevation Myocardial Infarction (STEMI)

          -  Subject with Chronic Total Occlusion (CTO)

          -  Subject undergoing PCI for isolated ostial disease of Left Main Coronary Artery (LMCA)
             or Right Coronary Artery (RCA)

          -  Subject undergoing PCI with Optical Coherence Tomography (OCT) support

          -  Subject undergoing PCI with rotational or orbital atherectomy

          -  Subject with Chronic Kidney Disease (CKD) stage V (eGFR &lt; 15 ml/min/1.73 m2)

          -  Subject with contrast allergy that cannot be adequately pre-medicated

          -  Subject participates in a potentially confounding drug or device trial during the
             course of the study.

          -  Subject is under 18 years of age, or pregnant woman, or breast feeding woman, or meets
             an exclusion criteria according to national law
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Eshuis, PhD</last_name>
    <phone>+31628739280</phone>
    <email>peter.g.eshuis@philips.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Messenger, MD</last_name>
      <email>john.messenger@ucdenver.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center/NYPH</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manish Parikh, MD</last_name>
      <email>map2224@cumc.columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grand Hôpital de Charleroi Saint-Joseph</name>
      <address>
        <city>Charleroi</city>
        <zip>6060</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric De Vroey, MD</last_name>
      <email>frederic.devroey@ghdc.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haim Danenberg, MD</last_name>
      <email>haimd@ekmd.huji.ac.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Carlos Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Escaned, MD</last_name>
      <phone>+34913303438</phone>
      <email>javier.escaned@salud.madrid.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Israel</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>September 9, 2019</study_first_submitted>
  <study_first_submitted_qc>September 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2019</study_first_posted>
  <last_update_submitted>February 6, 2020</last_update_submitted>
  <last_update_submitted_qc>February 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

